Literature DB >> 16051946

Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires.

Yin-Bun Cheung1, Cynthia Goh, Julian Thumboo, Kei-Siong Khoo, Joseph Wee.   

Abstract

PURPOSE: To compare the variability and sample size requirements of the global quality-of-life (QOL) scores of the following three major QOL instruments: the Functional Assessment of Cancer Therapy-General (FACT-G), Functional Living Index-Cancer (FLIC), and European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire C30 (EORTC QLQ-C30). PATIENTS AND METHODS: Cancer patients were randomly assigned to answer two of the three instruments using an incomplete block design (n = 1,268). The instruments were compared in terms of coefficient of variation, effect size in detecting a difference between patients with different performance status, and correlation coefficient between scores at baseline and follow-up.
RESULTS: The FACT-G and FLIC had significantly smaller coefficients of variation than the EORTC QLQ-C30 (both P < .05). The FLIC also had significantly larger correlation coefficients between scores at baseline and follow-up than the EORTC QLQ-C30 (P < .05). The FACT-G and the FLIC had a larger effect size in a cross-sectional and longitudinal setting, respectively, than the EORTC QLQ-C30 in differentiating patients with different performance status (both P < .05).
CONCLUSION: In some aspects, the FACT-G and FLIC global QOL scores had smaller variability and larger discriminative ability than the EORTC QLQ-C30. Further research using other criteria to compare the three instruments is recommended.

Entities:  

Mesh:

Year:  2005        PMID: 16051946     DOI: 10.1200/JCO.2005.07.141

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  19 in total

1.  The English and Chinese versions of the five-level EuroQoL Group's five-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients.

Authors:  Chun Fan Lee; Raymond Ng; Nan Luo; Nan Soon Wong; Yoon Sim Yap; Soo Kien Lo; Whay Kuang Chia; Alethea Yee; Lalit Krishna; Celest Wong; Cynthia Goh; Yin Bun Cheung
Journal:  Support Care Cancer       Date:  2012-06-06       Impact factor: 3.603

2.  Response and non-response to a quality-of-life question on sexual life: a case study of the simple mean imputation method.

Authors:  Yin Bun Cheung; Rhian Daniel; Gim Yew Ng
Journal:  Qual Life Res       Date:  2006-05-27       Impact factor: 4.147

3.  The Functional Living Index-Cancer is a reliable and valid instrument in Chinese cancer patients.

Authors:  Daniel Y T Fong; Alvina H K Lee; Stewart Y Tung; Janet Y H Wong; Y M Chan; Cynthia R Goh; Y B Cheung
Journal:  Qual Life Res       Date:  2013-06-18       Impact factor: 4.147

4.  Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.

Authors:  Barbara Deschler; Gabriele Ihorst; Uwe Platzbecker; Ulrich Germing; Eva März; Marcelo de Figuerido; Kurt Fritzsche; Peter Haas; Helmut R Salih; Aristoteles Giagounidis; Dominik Selleslag; Boris Labar; Theo de Witte; Pierre Wijermans; Michael Lübbert
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

5.  Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group's 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT-B), in Asian breast cancer patients.

Authors:  Chun Fan Lee; Nan Luo; Raymond Ng; Nan Soon Wong; Yoon Sim Yap; Soo Kien Lo; Whay Kuang Chia; Alethea Yee; Lalit Krishna; Celest Wong; Cynthia Goh; Yin Bun Cheung
Journal:  Qual Life Res       Date:  2012-10-11       Impact factor: 4.147

6.  Validation of the Chinese version of functional assessment of anorexia-cachexia therapy (FAACT) scale for measuring quality of life in cancer patients with cachexia.

Authors:  Ting Zhou; Kaixiang Yang; Sudip Thapa; Qiang Fu; Yongsheng Jiang; Shiying Yu
Journal:  Support Care Cancer       Date:  2016-11-29       Impact factor: 3.603

7.  An explorative randomised phase II study of sequential chemotherapy in advanced upper gastrointestinal cancer.

Authors:  Ake Berglund; Per Byström; Birgitta Johansson; Peter Nygren; Jan-Erik Frödin; Dorte Pedersen; Henry Letocha; Bengt Glimelius
Journal:  Med Oncol       Date:  2009-02-11       Impact factor: 3.064

Review 8.  Health-related quality of life in patients with high-grade glioma.

Authors:  Jin-xiang Cheng; Xiang Zhang; Bo-Lin Liu
Journal:  Neuro Oncol       Date:  2008-07-15       Impact factor: 12.300

9.  Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients.

Authors:  Dona E C Locke; Paul A Decker; Jeff A Sloan; Paul D Brown; James F Malec; Matthew M Clark; Teresa A Rummans; Karla V Ballman; Paul L Schaefer; Jan C Buckner
Journal:  J Pain Symptom Manage       Date:  2007-08-20       Impact factor: 3.612

Review 10.  Incorporating Quality of Life Metrics in Interventional Oncology Practice.

Authors:  David Li; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.